Introduction: Management of congestive heart failure is a serious public health problem. The use of implantable hemodynamic monitors (IHMs) may assist in this management by providing continuous ...
Please provide your email address to receive an email when new articles are posted on . In women with small aortic annuli who underwent TAVR, a self-expanding valve conferred better 1-year hemodynamic ...
Acorai, a clinical-stage company pioneering non-invasive hemodynamic monitoring for heart failure management, this week ...
Ventura et al. [27] have described the value of ICG for use in both research and clinical settings. Widespread clinical use has been reported with an estimated 2 million monitoring sessions to date, a ...
WASHINGTON, DC—For patients who present with STEMI complicated by cardiogenic shock (STEMI-CS), it’s not news that the long-awaited DanGer Shock trial showed better 180-day survival after Impella CP ...
Please provide your email address to receive an email when new articles are posted on . In patients with small aortic annuli requiring TAVR, self-expanding valves had better hemodynamic results than ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--PercAssist, Inc., a medical device company developing innovative technology for a minimally invasive, extravascular platform to provide hemodynamic support for ...
ATLANTA, GA—Compared with a balloon-expandable valve, TAVI with a self-expanding supra-annular valve results in similar rates of clinical outcomes at 1 year but offers lower rates of bioprosthetic ...
Relief Cardiovascular today announced the successful first-in-human use of its transcatheter smart heart implant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback